Trial Profile
A Single-dose Pharmacokinetic Trial of 0.03 mg/kg R108512 Solution in Paediatric Subjects, Aged ≥ 4 to ≤ 12 Years With Functional Faecal Retention (FFR).
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Apr 2015
Price :
$35
*
At a glance
- Drugs Prucalopride (Primary)
- Indications Constipation
- Focus Pharmacokinetics
- Sponsors Shire-Movetis NV
- 24 Apr 2015 New trial record